Clinuvel Pharmaceuticals Ltd

Retained, source-linked public records. Missing information does not imply that the company has no such information.

Security directory snapshot: 2026-11-17T01:30:34.911Z (not the page refresh time).

Company information and sources

CIK 0001290877

Official website
Not verified
Business description
In its 20-F filed 2026-10-30 (report period 2026-06-30), Clinuvel describes research, development and commercialization of treatments for rare and severe skin disorders, particularly light sensitivity and pigmentation.
Evidence observed: 2026-10-30T12:46:05.101Z
Profile content revised: 2026-11-12 · Evidence
Industry and source classification
Not verified
Jurisdiction of incorporation
SEC DEI — Australia
Evidence observed: 2026-10-30T12:46:05.101Z
Profile content revised: 2026-11-12 · Evidence
Business jurisdiction
Not verified
Country (consistent scope not assumed)
Not verified

Specific securities

Classifications belong to individual securities. No principal security is selected for a company with multiple securities.

Retained announcements and disclosures

All retained company activity

Open the complete company page and existing modules

Additional modules retain their existing access rules and may load separately.

How to research an OTC company